| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.762 | 37.649 | 43.242 | 44.963 | 53.424 | 61.997 | 53.703 | 59.276 | 59.229 | 57.796 |
| Total Income - EUR | 32.405 | 37.661 | 48.233 | 48.294 | 55.357 | 71.763 | 53.703 | 59.550 | 60.523 | 58.319 |
| Total Expenses - EUR | 31.429 | 38.106 | 45.409 | 47.679 | 54.788 | 60.202 | 52.036 | 58.804 | 59.842 | 56.991 |
| Gross Profit/Loss - EUR | 976 | -445 | 2.823 | 615 | 568 | 11.561 | 1.666 | 745 | 682 | 1.328 |
| Net Profit/Loss - EUR | 4 | -1.198 | 2.341 | 126 | 10 | 10.878 | 1.140 | 150 | 76 | 740 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 |
Check the financial reports for the company - Biocrida Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.584 | 2.523 | 2.992 | 3.696 | 3.345 | 3.513 | 3.544 | 1.925 | 2.805 | 4.361 |
| Inventories | 3.141 | 1.924 | 1.440 | 2.072 | 1.560 | 1.876 | 1.916 | 1.477 | 1.608 | 1.995 |
| Receivables | 301 | 590 | 1.464 | 1.340 | 1.381 | 1.531 | 1.498 | 101 | 181 | 303 |
| Cash | 143 | 9 | 88 | 283 | 404 | 106 | 130 | 347 | 1.017 | 2.062 |
| Shareholders Funds | -17.347 | -17.892 | -15.224 | -14.713 | -14.086 | -2.941 | -1.751 | -1.633 | -1.552 | -803 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.932 | 20.415 | 18.216 | 18.409 | 17.431 | 6.455 | 5.294 | 3.559 | 4.357 | 5.165 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Biocrida Srl